Covaxin Booster Dose
-
{
- All
- News
- Videos
-
Top Medical Body ICMR's Study Indicates Covaxin Booster Dose Safe: Centre
An ICMR study has indicated that a booster dose of Covaxin is safe and necessary to ensure persistent immunity to minimise breakthrough infections of COVID-19, Minister of State for Health Bharati Pravin Pawar informed Parliament on Friday.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Japan Approves Covaxin Booster Dose For Travellers: Bharat Biotech
Bharat Biotech on Friday said Japan has approved Covaxin booster dosage for travellers visiting the country.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin, Covishield Recipients Had Same Infection Rate In 3rd Wave: Study
Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
-
Covid Booster Shots Off To A Slow Start In Delhi
Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.
-
Covishield, Covaxin Prices Cut To Rs 225 Day Before Booster Drive Begins
Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.
-
Top Medical Body ICMR's Study Indicates Covaxin Booster Dose Safe: Centre
An ICMR study has indicated that a booster dose of Covaxin is safe and necessary to ensure persistent immunity to minimise breakthrough infections of COVID-19, Minister of State for Health Bharati Pravin Pawar informed Parliament on Friday.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Japan Approves Covaxin Booster Dose For Travellers: Bharat Biotech
Bharat Biotech on Friday said Japan has approved Covaxin booster dosage for travellers visiting the country.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin, Covishield Recipients Had Same Infection Rate In 3rd Wave: Study
Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
-
Covid Booster Shots Off To A Slow Start In Delhi
Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.
-
Covishield, Covaxin Prices Cut To Rs 225 Day Before Booster Drive Begins
Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.
